Bones Flashcards
Osteopersosis
- Fragility of skeleton due to loss of bone architecture
- Most common in post menopausal women [primary or type I osteoporosis]
- Can also be seen from other disease states—hyperthyroidism, use of steroids, anti-seizure or blood thinning agents [secondary osteoporosis]
Type I Osteoperosis
caused by post menopause-cause by bone resorption that is out of proportion to bone formation
Therapy for osteoperosis
• Adequate dietary Calcium and Vitamin D
• Weight bearing exercise [it stimulates bone growth]
• Smoking cessation; avoidance of ETOH [both mute bone formation]
• Avoid [if possible] drugs that increase bone loss—steroids, anti-psychotics, anti-epileptic agents, others
• When these drugs must be used—baseline DEXA should be done and then yearly while on these
medications
Secondary osteoperosis
is defined as bone loss that results from specific, well-defined clinical disorders. Many times reversible, secondary causes of bone loss are not considered in a patient with low bone mineral density (BMD).
Difference between osteopenia and osteoporosis
Bone density of -1.0 to -2.5 is osteopenia
Bone density of -2.5 or below is osteoporosis
Bone Density (DEXA scan)
• Compares thickness of bones to a normal
• In young adults, compared to an aged matched control and Z score is evaluated
• In middle aged and older adults, compared to a 35 y/o adult, same gender, comparable height, weight and
race and T score is evaluated
• Patient’s score [Z or T] is used to decide if
treatment needed—a score of -2.5 or
more standard deviations below normal
is osteoporosis
What do bisphosphonates do?
decrease osteoclast bone resorption
FRAX score (fracture risk assessment tool)
A FRAX score indicates the risk of a fracture in a person with osteoporosis. Doctors can use it to determine the best measures to prevent fractures and treat the condition.
BISPHOSPHONATE:
Drug name: Alendronate
Brand Name: Fosamax and Binosto
Can be given daily or weekly
• Binosto is an effervescent tablet
• Given in AM with 4-8 ounces of water 30-60” AC breakfast [no recumbancy for 30-60”]
• Thought to have worst GI side effect profile
• Approved for prevention and treatment of osteoporosis of hip and spine
• Rapidly cleared from plasma—binds to hydroxyapalite in the bone; once bound they are
cleared over months to years; renally eliminated [cannot be given in severe renal disease—
GFR <35 cc/min]
• ADE—GI distress, esophagitis, osteonecrosis of jaw [associated with high doses over long
periods3 consecutive years]; atypical fractures [seen with long term use]
BISPHOSPHONATE
Drug name: Risedronate
Brand name: Actonel, Atelvia Route: PO Approved use for: hip and spine disease DOSAGE: 35 mg (weekly) PO 150mg (monthly) PO 35 mg pc (weekly)
BISPHOSPHONATE
Drug name: Ibandronate
Brand name: Boniva
Route: PO or IVP
Approved use for: spine disease
BISPHOSOPHONATE
Drug name: Zoledronic acid
Brand name: Reclast, Zometa
Route: IV infusion YEARLY
Approved use for: hip and spine disease
*contraindication: heart issues or high risk for a fib ; can have some flu like symptoms
second line agents for osteoperosis
- estrogens
- younger, healthy women for short amount of time - selective estrogen receptor blockers
- given for people intolerant to bisphosphonates, hx breast cancer, contraindicatated for women with hx of DVT, stroke, etc
SE: hot flashes
Selective Estrogen Receptor Blockers
Drug name: Raloxifene (EVISTA)
Brand name: Evista
- Oral daily agent – used for women intolerant to bisphosphonates
- It has estrogen like effects on bone and estrogen antagonistic effects on breast and endometrium
- This agent also lowers LDL cholesterol
- CONTRAINDICATED in women with prior history of thromboembolic disease [DVT, stroke, etc.]
- Main SE—HOT FLASHES!! MAJOR! 35% IN WOMEN
Selective Estrogen Receptor Blockers
Drug name: DUAVE (Bazedoxifne/conjugated estrogens)
Brand name: Duavee
• 0.45/20 [1] tab daily
• Approved for vasomotor sx of menopause and osteoporosis prevention
• Estrogen + SERM—CANNOT be used in those with INTACT UTERUS; hx of breast, endometrial, ovarian cancers
- ADE—thromboembolism
- Same precautions as for estrogens & Evista